Tagged with Biotech,

pharma Leonardo Vingiani, Director of Assobiotec, discusses how the country’s biotech industry has evolved since 2009, what areas still need improving and the enormous progress which has been made in unlocking the sector’s potential in Italy. Leonardo, to start off, what are some of the major milestones which the industry, and…

Pharma The head of Aspen sterile operations and managing director of Aspen NDB, reveals how their facility in France acts as the main platform for the group´s sterile business, a market with tremendous potential at the world level; how the factory has a particularly strong international exposure, exporting 75 percent of…

Pharma The CEO of BioTech Africa, Jason Lurie, evaluates the domestic and global landscape for diagnostic recombinant proteins, and highlights other developmental streams that have helped diversify the company’s portfolio. He also illustrates the underlying aspirations in targeting this market niche, while depicting the distinct set of hurdles faced from the…

pharma The CEO of BioConnection, the leading contract services and manufacturing organization for the development and production of injectable (bio)pharmaceutical products, explains how —thanks to flexibility and quality-driven mentality —the company helps small and medium biotech companies and universities make their products reality. This year BioConnection celebrates its tenth anniversary and…

pharma The Netherlands provides a flourishing environment for biotech to grow. The vice president for European operations at Kite Pharma discusses how biotech start-ups can find their path to success and how Kite Pharma is looking at new innovative therapies for cancer treatment. Before joining T-Cell Factory, later acquired by Kite…

pharma Hans Schikan offers insights into the flourishing Dutch life sciences sector and the attractiveness of the local eco-system, citing a combination of the right science and the right attitude of people as the key formula for success. In 2014/2015, three Dutch biotechs (UniQure, ProQR, Galapagos) went public on Nasdaq, and…

Pharma Puerto Rico is not only an important manufacturing hub, but is also positioning itself as a state-of-the-art center for R&D and clinical research. Iván Lugo, the executive director of the Industry University Research Center Inc. (INDUNIV), which brings together private sector, academia and government, discusses some of the island’s most…

Pharma Maribel Rodríguez-Torres of Fundación de Investigación assesses the current R&D situation in Puerto Rico, explains the activities of the center as well as some of their most important success stories. The Fundación is Puerto Rico’s largest research center and the only Phase 1 research clinical trials unit in Latin America and the Caribbean. What is your assessment…

pharma Haluk Ataoglu, academic turned founder of Matriks Biotek®, talks about his aspirations for his company and the Turkish R&D landscape as well as how to penetrate the global pharmaceutical market as a Turkish brand. As an introduction Haluk, can you tell us what your initial aspirations were in starting Matriks…

Pharma The Chairman & CEO of DBV Technologies reveals how they have developed a new therapeutic method and new technology in the form of a patch to treat various allergies. DBV received a “breakthrough” designation from the FDA for the design which meets safety standards that no other products currently being developed do.…

Pharma Miroslav Secerov, VP Sales & Marketing NATEC, explains the choice of Mauritius for NATEC’s headquarters as well as the unique assets that make Mauritius the ideal business location. He also analyses Mauritius’ recent emphasis on development of the life sciences sector and the public-private relationship required to make that a…

Pharma The General Manager of LEEM talks about the association’s strategy based on three key points, innovation, attractiveness and efficiency; how the Mediator affair has placed a question mark on the championing of the pharma industry as a national asset; why both France and Europe are at turning point and what…